Your browser doesn't support javascript.
loading
Hematopoietic stem cell involvement in BCR-ABL1-positive ALL as a potential mechanism of resistance to blinatumomab therapy.
Nagel, Inga; Bartels, Marius; Duell, Johannes; Oberg, Hans-Heinrich; Ussat, Sandra; Bruckmueller, Henrike; Ottmann, Oliver; Pfeifer, Heike; Trautmann, Heiko; Gökbuget, Nicola; Caliebe, Almuth; Kabelitz, Dieter; Kneba, Michael; Horst, Heinz-August; Hoelzer, Dieter; Topp, Max S; Cascorbi, Ingolf; Siebert, Reiner; Brüggemann, Monika.
Afiliación
  • Nagel I; Institute of Human Genetics and.
  • Bartels M; Institute of Experimental and Clinical Pharmacology, Christian-Albrechts University Kiel and University Hospital Schleswig-Holstein, Kiel, Germany.
  • Duell J; Department of Hematology, University Hospital Schleswig-Holstein, Kiel, Germany.
  • Oberg HH; Department of Internal Medicine II, Universitätsklinikum, Würzburg, Germany.
  • Ussat S; Institute of Immunology, University Hospital Schleswig-Holstein, Kiel, Germany.
  • Bruckmueller H; Institute of Immunology, University Hospital Schleswig-Holstein, Kiel, Germany.
  • Ottmann O; Institute of Experimental and Clinical Pharmacology, Christian-Albrechts University Kiel and University Hospital Schleswig-Holstein, Kiel, Germany.
  • Pfeifer H; Second Medical Department, University Hospital, Frankfurt, Germany.
  • Trautmann H; Division of Cancer and Genetics, Department of Haematology, School of Medicine, Cardiff University, Cardiff, United Kingdom; and.
  • Gökbuget N; Second Medical Department, University Hospital, Frankfurt, Germany.
  • Caliebe A; Department of Hematology, University Hospital Schleswig-Holstein, Kiel, Germany.
  • Kabelitz D; Second Medical Department, University Hospital, Frankfurt, Germany.
  • Kneba M; Institute of Human Genetics and.
  • Horst HA; Institute of Immunology, University Hospital Schleswig-Holstein, Kiel, Germany.
  • Hoelzer D; Department of Hematology, University Hospital Schleswig-Holstein, Kiel, Germany.
  • Topp MS; Department of Hematology, University Hospital Schleswig-Holstein, Kiel, Germany.
  • Cascorbi I; Second Medical Department, University Hospital, Frankfurt, Germany.
  • Siebert R; Department of Internal Medicine II, Universitätsklinikum, Würzburg, Germany.
  • Brüggemann M; Institute of Experimental and Clinical Pharmacology, Christian-Albrechts University Kiel and University Hospital Schleswig-Holstein, Kiel, Germany.
Blood ; 130(18): 2027-2031, 2017 11 02.
Article en En | MEDLINE | ID: mdl-28827408
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Células Madre Hematopoyéticas / Leucemia-Linfoma Linfoblástico de Células Precursoras B / Proteínas de Fusión bcr-abl / Anticuerpos Biespecíficos / Resistencia a Antineoplásicos Tipo de estudio: Clinical_trials Límite: Adult / Humans Idioma: En Revista: Blood Año: 2017 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Células Madre Hematopoyéticas / Leucemia-Linfoma Linfoblástico de Células Precursoras B / Proteínas de Fusión bcr-abl / Anticuerpos Biespecíficos / Resistencia a Antineoplásicos Tipo de estudio: Clinical_trials Límite: Adult / Humans Idioma: En Revista: Blood Año: 2017 Tipo del documento: Article